Ignite Creation Date:
2024-05-06 @ 8:28 PM
Last Modification Date:
2024-10-26 @ 3:28 PM
Study NCT ID:
NCT06394414
Status:
RECRUITING
Last Update Posted:
2024-05-17
First Post:
2024-04-23
Brief Title:
A Phase 1 Study to Evaluate the Safety Efficacy and Pharmacokinetics of YL201 in Advanced Solid Tumors
Sponsor:
MediLink Therapeutics Suzhou Co Ltd
Organization:
MediLink Therapeutics Suzhou Co Ltd
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Advanced Solid Tumors |
Keywords: